Paul-Adrian Calburean
Overview
Explore the profile of Paul-Adrian Calburean including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
76
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pannone L, Della Rocca D, Vergara P, Sorgente A, Del Monte A, Vetta G, et al.
Circ Arrhythm Electrophysiol
. 2024 Dec;
17(12):e013290.
PMID: 39624903
Background: Brugada syndrome (BrS) is associated with ventricular fibrillation (VF). Different VF mechanisms have been described, and repolarization gradients were associated with VF in a BrS model. The aim of...
2.
Calburean P, Grebenisan P, Nistor I, Sulea I, Scurtu A, Brinzaniuc K, et al.
J Epidemiol Community Health
. 2024 Nov;
79(4):272-279.
PMID: 39532395
Background: Long-term outcomes in cardiovascular diseases are historically under-reported in Eastern Europe. Our aim was to report long-term survival and to identify survival predictors in a prospective Romanian percutaneous coronary...
3.
Calburean P, Harpa M, Scurtu A, Grebenisan P, Nistor I, Vacariu V, et al.
Sci Rep
. 2024 Oct;
14(1):24837.
PMID: 39438608
Out-of-hospital mortality in coronary artery disease (CAD) is particularly high and established adverse event prediction tools are yet to be available. Our study aimed to investigate whether precision phenotyping can...
4.
Calburean P, Lupu S, Hutanu A, Oprica M, Opris D, Stan A, et al.
Sci Rep
. 2024 Sep;
14(1):22171.
PMID: 39333652
Elevated filling pressure of the left ventricle (LV) defines diastolic dysfunction. The gold standard for diagnosis is represented by the measurement of LV end-diastolic pressure (LVEDP) during cardiac catheterization, but...
5.
Calburean P, Grebenisan P, Nistor I, Pal K, Vacariu V, Drincal R, et al.
Front Pharmacol
. 2024 Jun;
15:1415025.
PMID: 38939835
Current guidelines recommend that glycoprotein IIb/IIIa inhibitor (GPI) and manual aspiration thrombectomy should not be routinely used in patients with ST-segment elevation myocardial infarction (STEMI) treated by primary percutaneous coronary...
6.
Calburean P, Pannone L, Monaco C, Della Rocca D, Sorgente A, Almorad A, et al.
J Am Heart Assoc
. 2024 May;
13(10):e033148.
PMID: 38726893
Background: Brugada syndrome (BrS) has been associated with sudden cardiac death in otherwise healthy subjects, and drug-induced BrS accounts for 55% to 70% of all patients with BrS. This study...
7.
Stan A, Calburean P, Drinkal R, Harpa M, Elkahlout A, Nicolae V, et al.
Diagnostics (Basel)
. 2023 Sep;
13(18).
PMID: 37761276
(1) Background: Although transcatheter aortic valve replacement (TAVR) significantly improves long-term outcomes of symptomatic severe aortic stenosis (AS) patients, long-term mortality rates are still high. The aim of our study...
8.
Calburean P, Pannone L, Sorgente A, Gauthey A, Monaco C, Strazdas A, et al.
Clin Auton Res
. 2023 Jan;
33(1):51-62.
PMID: 36645559
Purpose: Drug-induced type I Brugada syndrome (BrS) is associated with a ventricular arrhythmia (VA) rate of 1 case per 100 person-years. This study aims to evaluate changes in electrocardiographic (ECG)...
9.
Monaco C, Galli A, Pannone L, Bisignani A, Miraglia V, Gauthey A, et al.
Am J Cardiol
. 2022 Aug;
181:45-54.
PMID: 35973836
Management of ventricular arrhythmias (VAs) beyond implantable cardioverter-defibrillator positioning in patients with arrhythmogenic right ventricular cardiomyopathy (ARVC) is challenging. Catheter ablation of the ventricular substrate often requires a combination of...
10.
Calburean P, Grebenisan P, Nistor I, Pal K, Vacariu V, Drincal R, et al.
Atherosclerosis
. 2022 Apr;
350:33-40.
PMID: 35483116
Background And Aims: Machine learning (ML) models have been proposed as a prognostic clinical tool and superiority over clinical risk scores is yet to be established. Our aim was to...